lg 100268 has been researched along with Acute Myelogenous Leukemia in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sanchez, PV | 1 |
Glantz, ST | 1 |
Scotland, S | 1 |
Kasner, MT | 1 |
Carroll, M | 1 |
1 other study available for lg 100268 and Acute Myelogenous Leukemia
Article | Year |
---|---|
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
Topics: Bexarotene; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cell Differentiat | 2014 |